首页 产品目录 分子砌块 按官能团 醇类 (3S,8S,9S,10R,13R,14S,17R)-17-((R,E)-5-异丙基庚-5-烯-2-基)-10,13-二甲基-2,3,4,7,8,9,10,11,12,13,14,15,16,17-十四氢-1H-环戊并[a]菲-3-醇

(3S,8S,9S,10R,13R,14S,17R)-17-((R,E)-5-异丙基庚-5-烯-2-基)-10,13-二甲基-2,3,4,7,8,9,10,11,12,13,14,15,16,17-十四氢-1H-环戊并[a]菲-3-醇

(3S,8S,9S,10R,13R,14S,17R)-17-((R,E)-5-isopropylhept-5-en-2-yl)-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-ol

产品编号 :
Cas No. :
包装规格 纯度 目录价 会员专享价 库存 数量
25mg 95% 询价
- +
50mg 95% 询价
- +
100mg 95% 询价
- +
250mg 95% 询价
- +
晶智化学产品均仅供科研使用。在任何情况下,我们均不提供用于动物或人体用途的产品或服务。

基础信息

CAS No.

17605-67-3

中文名称

(3S,8S,9S,10R,13R,14S,17R)-17-((R,E)-5-异丙基庚-5-烯-2-基)-10,13-二甲基-2,3,4,7,8,9,10,11,12,13,14,15,16,17-十四氢-1H-环戊并[a]菲-3-醇

英文名称

(3S,8S,9S,10R,13R,14S,17R)-17-((R,E)-5-isopropylhept-5-en-2-yl)-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-ol

别名

Stigmasta-5,24(28)-dien-3-ol, (3beta,24E)-;trans-24-Ethylidenecholesterol;FUCOSTEROL;5,24(28)E-CHOLESTADIEN-24-ETHYL-3BETA-OL;5,24[28]-STIGMASTADIEN-3BETA-OL;3BETA-HYDROXY-5,24[28]-STIGMASTADIENE;5-CHOLESTEN-24(28)-ETHYLIDENE-3-BETA-OL;24-ETHYLIDENCHOLEST-5-ENE-3BETA-OL

标准英文名

(3S,8S,9S,10R,13R,14S,17R)-17-((R,E)-5-isopropylhept-5-en-2-yl)-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-ol

分子式

C29H48O

分子量

412.37

精确分子量

412.37

SMILES

C[C@@]12[C@](CC[C@]2([H])[C@H](C)CC/C(C(C)C)=C\C)([H])[C@@]3([H])[C@@](CC1)([H])[C@@]4(C(C[C@H](CC4)O)=CC3)C

标准SMILES

CC(C)/C(/CC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C)=C/C

用途

Fucosterol exhibits multiple biological activities, including antioxidant, anti-adipogenic, blood cholesterol-lowering, anti-diabetic, and anticancer effects; it suppresses adipogenesis by inhibiting the expression of PPARα and C/EBPα, showing potential for anti-obesity agent development; it demonstrates cytotoxicity against T47D and HT29 cancer cell lines (IC50 = 27.94 and 70.41 μg/mL, respectively); it inhibits proliferation of HEK293, MCF-7, and SiHa cells (IC50 = 185.4, 43.3, and 34.0 μg/mL, respectively); and in vivo, it significantly reduces serum glucose levels and inhibits sorbitol accumulation in the lenses upon oral administration (30 mg/kg).

InChIKey

OSELKOCHBMDKEJ-JUGJNGJRSA-N

安全信息

SureRoute逆合成路线

1.  17605-67-3 逆合成路线 1

—
—
ACXNOH692
17605-67-3
来源: SureRoute

2.  17605-67-3 逆合成路线 2

—
—
ACXNOH692
17605-67-3
来源: SureRoute

3.  17605-67-3 逆合成路线 3

—
—
ACXNOH692
17605-67-3
来源: SureRoute
评论 0
我是晶智Agent,
您的化学小助手